Soros Fund Management »

Protagonist Therapeutics shares owned by Soros Fund Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Soros Fund Management from 13F filings

Historical chart of Soros Fund Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Soros Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Soros Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.7M 100k 87.34

More positions owned by Soros Fund Management

Amazon (AMZN)
Spdr Series Trust State Street Spd Put Option (XOP)
Spotify Usa Note 3/1 (Principal)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rivian Automotive Note 4.625% 3/1 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Select Sector Spdr Tr State Street Ene Put Option (XLE)
Confluent Note 1/1 (Principal)
salesforce (CRM)
Dropbox Note 3/0 (Principal)
Pg&e Corp Note 4.250%12/0 (Principal)
Tko Group Holdings Cl A (TKO)
Microsoft Corporation (MSFT)

View all positions for Soros Fund Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics